1. Home
  2. EDIT vs FFIE Comparison

EDIT vs FFIE Comparison

Compare EDIT & FFIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • FFIE
  • Stock Information
  • Founded
  • EDIT 2013
  • FFIE 2014
  • Country
  • EDIT United States
  • FFIE United States
  • Employees
  • EDIT N/A
  • FFIE N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • FFIE Auto Manufacturing
  • Sector
  • EDIT Health Care
  • FFIE Consumer Discretionary
  • Exchange
  • EDIT Nasdaq
  • FFIE Nasdaq
  • Market Cap
  • EDIT 108.1M
  • FFIE 97.5M
  • IPO Year
  • EDIT 2016
  • FFIE N/A
  • Fundamental
  • Price
  • EDIT $1.92
  • FFIE $1.60
  • Analyst Decision
  • EDIT Buy
  • FFIE
  • Analyst Count
  • EDIT 14
  • FFIE 0
  • Target Price
  • EDIT $8.08
  • FFIE N/A
  • AVG Volume (30 Days)
  • EDIT 5.8M
  • FFIE 11.5M
  • Earning Date
  • EDIT 03-03-2025
  • FFIE 11-06-2024
  • Dividend Yield
  • EDIT N/A
  • FFIE N/A
  • EPS Growth
  • EDIT N/A
  • FFIE N/A
  • EPS
  • EDIT N/A
  • FFIE N/A
  • Revenue
  • EDIT $61,759,000.00
  • FFIE $537,000.00
  • Revenue This Year
  • EDIT N/A
  • FFIE $10,958.67
  • Revenue Next Year
  • EDIT N/A
  • FFIE $617.65
  • P/E Ratio
  • EDIT N/A
  • FFIE N/A
  • Revenue Growth
  • EDIT 150.95
  • FFIE N/A
  • 52 Week Low
  • EDIT $1.12
  • FFIE $0.99
  • 52 Week High
  • EDIT $11.58
  • FFIE $156.00
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 55.72
  • FFIE 51.72
  • Support Level
  • EDIT $1.12
  • FFIE $1.49
  • Resistance Level
  • EDIT $3.30
  • FFIE $1.86
  • Average True Range (ATR)
  • EDIT 0.30
  • FFIE 0.18
  • MACD
  • EDIT 0.12
  • FFIE 0.04
  • Stochastic Oscillator
  • EDIT 36.70
  • FFIE 46.84

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About FFIE Faraday Future Intelligent Electric Inc.

Faraday Future Intelligent Electric Inc is a global shared intelligent mobility ecosystem. It is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models.

Share on Social Networks: